
A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses to the $17 billion …

In the run-up to the UK’s general election in June, government spending within the life sciences industry has become a …

The FDA has granted accelerated approval to AstraZeneca’s (AZ) immunotherapy therapy Imfinzi (durvalumab) for the treatment of locally advanced or …

Scientists at Shanghai’s East China Normal University have been able to regulate blood sugar levels in mice via the use …

Janssen has announced that its CD38-directed monoclonal antibody Darzalex (daratumumab) has expanded its indication with a thumbs-up from the European …

Rare disease specialist Shire has opened the doors of its new headquarters in Dublin, Ireland. The pharma company has leased …

Trump’s pick for the top job in the FDA moved one step closer to taking up the job when the …

The Cancer Drug Fund (CDF), which has now been absorbed into NICE, previous methods of funding have been fiercely criticised …

In response to the announcement of a UK snap election, this week saw the release of the ABPI’s 2017 General …

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …

Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure …

SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …

A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients …

Here at Pharmafocus, we highlighted the state of mental health research and the alternative paths that are being trod to …

It’s no secret that mental health is not taken as seriously as its physical counterpart. It has been an uphill …

A drug that has been available to patients for many years may have found a new use to prevent mothers …

Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …

With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …

The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …